X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-18 | PHR | Roberts Evan | COO | S - Sale | $30.05 | -3,696 | 741,020 | 0% | -$111,074 | |||||
| M | 2025-02-18 | PHR | Gandhi Balaji | CFO | S - Sale | $30.04 | -5,867 | 105,418 | -5% | -$176,257 | |||||
2025-02-18 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $29.72 | -3,496 | 142,630 | -2% | -$103,901 | ||||||
| M | 2025-02-13 | PHR | Roberts Evan | COO | S - Sale | $30.02 | -19,591 | 744,716 | -3% | -$588,191 | |||||
| M | 2025-02-13 | PHR | Gandhi Balaji | CFO | S - Sale | $30.01 | -33,648 | 111,285 | -23% | -$1,009,858 | |||||
2025-02-13 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $29.70 | -11,616 | 226,986 | -5% | -$345,001 | ||||||
2025-02-07 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $29.52 | -300 | 238,602 | 0% | -$8,857 | ||||||
2025-02-05 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $29.50 | -720 | 238,902 | 0% | -$21,241 | ||||||
2025-01-29 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $29.68 | -500 | 239,622 | 0% | -$14,841 | ||||||
2025-01-27 | PHR | Gandhi Balaji | CFO | S - Sale | $27.48 | -4,813 | 144,933 | -3% | -$132,244 | ||||||
| M | 2025-01-27 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $27.98 | -12,791 | 146,126 | -8% | -$357,832 | |||||
2025-01-27 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $27.48 | -11,685 | 240,122 | -5% | -$321,060 | ||||||
2025-01-27 | PHR | Roberts Evan | COO | S - Sale | $27.48 | -10,716 | 764,307 | -1% | -$294,436 | ||||||
2025-01-27 | PHR | Indig Chaim | CEO | S - Sale | $27.48 | -26,248 | 1,515,200 | -2% | -$721,198 | ||||||
2025-01-27 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $27.48 | -3,475 | 114,734 | -3% | -$95,480 | ||||||
2025-01-24 | PHR | Hui Yvonne | Principal Accounting Officer | S - Sale | $28.00 | -127 | 25,647 | 0% | -$3,556 | ||||||
2025-01-21 | PHR | Gandhi Balaji | CFO | S - Sale | $27.31 | -5,827 | 141,846 | -4% | -$159,139 | ||||||
2025-01-21 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $27.31 | -8,426 | 146,126 | -5% | -$230,120 | ||||||
2025-01-21 | PHR | Roberts Evan | COO | S - Sale | $27.31 | -12,749 | 755,459 | -2% | -$348,184 | ||||||
2025-01-21 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $27.31 | -4,720 | 110,309 | -4% | -$128,907 | ||||||
2025-01-21 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $27.31 | -13,873 | 232,243 | -6% | -$378,881 | ||||||
2025-01-21 | PHR | Indig Chaim | CEO | S - Sale | $27.31 | -21,692 | 1,492,538 | -1% | -$592,424 | ||||||
2025-01-15 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $26.90 | -4,585 | 154,552 | -3% | -$123,320 | ||||||
2025-01-15 | PHR | Indig Chaim | CEO | S - Sale | $26.98 | -2,990 | 1,514,230 | 0% | -$80,674 | ||||||
2025-01-15 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $26.98 | -604 | 115,029 | -1% | -$16,297 | ||||||
2025-01-15 | PHR | Hui Yvonne | Principal Accounting Officer | S - Sale | $26.87 | -381 | 25,774 | -1% | -$10,237 | ||||||
2025-01-15 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $26.98 | -1,946 | 246,116 | -1% | -$52,506 | ||||||
2025-01-15 | PHR | Roberts Evan | COO | S - Sale | $26.98 | -1,785 | 768,208 | 0% | -$48,162 | ||||||
2025-01-15 | PHR | Gandhi Balaji | CFO | S - Sale | $26.98 | -836 | 147,673 | -1% | -$22,556 | ||||||
2025-01-14 | PHR | Hui Yvonne | Principal Accounting Officer | S - Sale | $26.38 | -362 | 26,155 | -1% | -$9,548 | ||||||
2025-01-10 | PHR | Hui Yvonne | Principal Accounting Officer | S - Sale | $27.85 | -388 | 26,517 | -1% | -$10,806 | ||||||
2025-01-08 | PHR | Roberts Evan | COO | S - Sale | $27.95 | -2,681 | 769,993 | 0% | -$74,940 | ||||||
2025-01-08 | PHR | Hui Yvonne | Principal Accounting Officer | S - Sale | $28.00 | -288 | 26,905 | -1% | -$8,064 | ||||||
| M | 2025-01-06 | PHR | Roberts Evan | COO | S - Sale | $26.89 | -10,192 | 772,674 | -1% | -$274,051 | |||||
2025-01-06 | PHR | Gandhi Balaji | CFO | S - Sale | $26.61 | -3,195 | 148,509 | -2% | -$85,005 | ||||||
2025-01-06 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $26.61 | -1,311 | 115,633 | -1% | -$34,880 | ||||||
2025-01-06 | PHR | Indig Chaim | CEO | S - Sale | $26.61 | -5,375 | 1,517,220 | 0% | -$143,005 | ||||||
2025-01-06 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $26.61 | -3,982 | 159,137 | -2% | -$105,943 | ||||||
2025-01-06 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $26.61 | -3,133 | 248,062 | -1% | -$83,355 | ||||||
2024-12-18 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $24.88 | -3,495 | 116,296 | -3% | -$86,956 | ||||||
2024-12-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $25.38 | -24 | 197,205 | 0% | -$609 | ||||||
| M | 2024-12-16 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $25.00 | -96 | 197,229 | 0% | -$2,400 | |||||
| DM | 2024-12-13 | PHR | Weintraub Michael | Dir | S - Sale+OE | $25.05 | -21,426 | 340,575 | -6% | -$536,790 | |||||
| D | 2024-12-11 | PHR | Weintraub Michael | Dir | S - Sale+OE | $25.10 | -18,574 | 340,575 | -5% | -$466,191 | |||||
2024-12-11 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $24.85 | -11,853 | 197,325 | -6% | -$294,559 | ||||||
2024-12-10 | PHR | Roberts Evan | COO | S - Sale | $24.09 | -25,000 | 728,876 | -3% | -$602,160 | ||||||
2024-12-03 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $20.93 | -25,447 | 93,470 | -21% | -$532,560 | ||||||
| D | 2024-12-02 | PHR | Weintraub Michael | Dir | S - Sale+OE | $21.01 | -15,152 | 340,575 | -4% | -$318,368 | |||||
2024-10-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $20.49 | -1,100 | 209,178 | -1% | -$22,539 | ||||||
2024-10-15 | PHR | Gandhi Balaji | CFO | S - Sale | $21.03 | -864 | 97,714 | -1% | -$18,166 | ||||||
2024-10-15 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $21.03 | -1,212 | 119,791 | -1% | -$25,482 | ||||||
2024-10-15 | PHR | Indig Chaim | CEO | S - Sale | $21.03 | -3,089 | 1,475,647 | 0% | -$64,947 | ||||||
2024-10-15 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $21.03 | -2,011 | 210,278 | -1% | -$42,281 | ||||||
2024-10-15 | PHR | Roberts Evan | COO | S - Sale | $21.03 | -1,843 | 753,876 | 0% | -$38,749 | ||||||
2024-10-15 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $21.03 | -624 | 118,917 | -1% | -$13,120 | ||||||
| M | 2024-10-15 | PHR | Hui Yvonne | Principal Accounting Officer | S - Sale | $20.98 | -3,214 | 26,805 | -11% | -$67,418 | |||||
2024-09-19 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $24.04 | -24 | 212,289 | 0% | -$577 | ||||||
| M | 2024-09-17 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $24.34 | -97 | 212,313 | 0% | -$2,361 | |||||
2024-09-12 | PHR | Egbuonu-Davis Lisa | Dir | S - Sale | $23.03 | -1,400 | 18,139 | -7% | -$32,239 | ||||||
2024-09-10 | PHR | Gandhi Balaji | CFO | S - Sale | $23.25 | -3,502 | 98,578 | -3% | -$81,422 | ||||||
2024-09-10 | PHR | Hui Yvonne | Principal Accounting Officer | S - Sale | $23.25 | -744 | 30,019 | -2% | -$17,298 | ||||||
2024-09-10 | PHR | Indig Chaim | CEO | S - Sale | $23.25 | -5,295 | 1,478,736 | 0% | -$123,110 | ||||||
2024-09-10 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.25 | -1,811 | 212,410 | -1% | -$42,106 | ||||||
2024-09-10 | PHR | Roberts Evan | COO | S - Sale | $23.25 | -3,148 | 755,719 | 0% | -$73,192 | ||||||
2024-09-10 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $23.25 | -737 | 119,541 | -1% | -$17,135 | ||||||
| M | 2024-09-10 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $23.30 | -4,694 | 121,003 | -4% | -$109,364 | |||||
2024-08-26 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $26.03 | -14,110 | 121,003 | -10% | -$367,241 | ||||||
| D | 2024-07-29 | PHR | Indig Chaim | CEO | S - Sale+OE | $24.75 | -7 | 1,474,361 | 0% | -$173 | |||||
| D | 2024-07-18 | PHR | Smith Mark Douglas | Dir | S - Sale+OE | $25.00 | -7,000 | 30,653 | -19% | -$175,000 | |||||
2024-07-16 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.74 | -1,820 | 209,171 | -1% | -$43,199 | ||||||
2024-07-16 | PHR | Indig Chaim | CEO | S - Sale | $23.74 | -2,644 | 1,474,361 | 0% | -$62,757 | ||||||
2024-07-16 | PHR | Hui Yvonne | Principal Accounting Officer | S - Sale | $23.74 | -283 | 28,714 | -1% | -$6,717 | ||||||
2024-07-16 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $23.74 | -800 | 135,113 | -1% | -$18,988 | ||||||
2024-07-16 | PHR | Gandhi Balaji | CFO | S - Sale | $23.74 | -783 | 96,447 | -1% | -$18,585 | ||||||
2024-07-16 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $23.74 | -374 | 118,636 | 0% | -$8,877 | ||||||
2024-07-16 | PHR | Roberts Evan | COO | S - Sale | $23.74 | -1,669 | 753,234 | 0% | -$39,615 | ||||||
2024-06-21 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $20.24 | -114 | 34,820 | 0% | -$2,307 | ||||||
2024-06-21 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $20.24 | -27 | 210,991 | 0% | -$546 | ||||||
| M | 2024-06-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $19.53 | -107 | 211,018 | 0% | -$2,089 | |||||
2024-05-01 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $21.00 | -286 | 34,934 | -1% | -$6,006 | ||||||
2024-04-18 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $22.85 | -912 | 35,220 | -3% | -$20,836 | ||||||
2024-04-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.85 | -269 | 211,125 | 0% | -$6,146 | ||||||
2024-04-15 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $22.86 | -685 | 119,010 | -1% | -$15,657 | ||||||
2024-04-15 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.86 | -2,212 | 211,394 | -1% | -$50,561 | ||||||
2024-04-15 | PHR | Roberts Evan | COO | S - Sale | $22.86 | -2,029 | 754,903 | 0% | -$46,378 | ||||||
2024-04-15 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $22.86 | -1,238 | 135,621 | -1% | -$28,297 | ||||||
2024-04-15 | PHR | Gandhi Balaji | CFO | S - Sale | $22.86 | -948 | 97,230 | -1% | -$21,669 | ||||||
2024-04-15 | PHR | Indig Chaim | CEO | S - Sale | $22.86 | -3,392 | 1,477,005 | 0% | -$77,532 | ||||||
2024-04-10 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $23.10 | -2,768 | 36,132 | -7% | -$63,928 | ||||||
| M | 2024-04-08 | PHR | Hoffman Allison C | GC, Secretary | S - Sale | $22.99 | -10,175 | 136,859 | -7% | -$233,879 | |||||
2024-04-08 | PHR | Gandhi Balaji | CFO | S - Sale | $22.62 | -7,778 | 98,178 | -7% | -$175,939 | ||||||
2024-04-08 | PHR | Indig Chaim | CEO | S - Sale | $22.62 | -12,043 | 1,480,397 | -1% | -$272,414 | ||||||
| M | 2024-04-08 | PHR | Vanduyn Amy Beth | SVP, HR | S - Sale | $23.05 | -7,122 | 119,695 | -6% | -$164,145 | |||||
| D | 2024-04-08 | PHR | Roberts Evan | COO | S - Sale+OE | $22.62 | -7,178 | 756,932 | -1% | -$162,367 | |||||
2024-04-08 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.62 | -4,161 | 213,606 | -2% | -$94,122 | ||||||
| M | 2024-03-19 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $23.03 | -4,526 | 38,900 | -10% | -$104,219 | |||||
2024-03-25 | PHR | Gandhi Balaji | CFO | S - Sale | $23.21 | -3,504 | 94,030 | -4% | -$81,332 | ||||||
2024-03-21 | PHR | Roberts Evan | COO | S - Sale | $23.52 | -25,962 | 728,570 | -3% | -$610,684 | ||||||
2024-03-20 | PHR | Gunzburg Janet | Principal Accounting Officer | S - Sale | $23.66 | -137 | 38,949 | 0% | -$3,241 | ||||||
2024-03-20 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.66 | -30 | 211,154 | 0% | -$710 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |